Browsing by Subject "MULTIPLE-MYELOMA"
Now showing items 1-5 of 5
-
Home administration of bortezomib: Making a difference to myeloma patients' lives
(Elsevier, 2009-10-08)Multiple myeloma is a clonal malignancy of plasma cells, characterized by anaemia, renal dysfunction, lytic bone lesions and the presence of excess monoclonal immunoglobulin. It is the second most common hematological ... -
Living with relapsed myeloma: Symptoms and self-care strategies
(Wiley, 2017-12-21)Aims and Objectives: To explore which symptoms relapsed myeloma patients experience and what self-care strategies are used.Methods: This was a qualitative study utilising focus group interviews (n=4) with relapsed myeloma ... -
Managing relapsed myeloma: The views of patients, nurses and doctors
(Elsevier, 2016-05-11)Purpose: The study aim was to explore whether there were differing opinions on the current management of relapsed myeloma between patients and health care professionals, a topic which has never been explored previously in ... -
Myeloma patients' experiences of haematopoietic stem cell transplant: A qualitative thematic synthesis
(Elsevier, 2018-05-15)Purpose: The aim of this study was to synthesise all qualitative evidence on the experiences of myeloma patients undergoing haematopoietic stem cell transplant (HSCT).Method: A systematic search strategy was developed and ... -
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
(Springer, 2008-06-04)Introduction The chemokines Stromal Cell-Derived Factor-1 alpha (SDF-1 alpha/CXCL12) and Monocyte Chemotactic Protein-1 (MCP-1/CCL2) have been implicated in breast cancer progression. We recently reported elevated systemic ...